Tetsu Ebara

988 citations

28 papers · 805 indexed · h-index 17

Impact in

Endocrinology, Diabetes and Metabolism top 5%
- Diabetes, Cardiovascular Risks, and Lipoproteins
Cardiology and Cardiovascular Medicine top 5%
- Lipid metabolism and disorders

Papers in

Cardiology and Cardiovascular Medicine 14
- Lipid metabolism and disorders 11
Endocrinology, Diabetes and Metabolism 10
- Diabetes, Cardiovascular Risks, and Lipoproteins 8

Co-authors: Neil S. Shachter George Steiner R Ramakrishnan Tsutomu Hirano Minoru Okubo Toshio Murase Mitsuru Adachi Seishi Nagano
Journals: Clinica Chimica Acta (4 papers)Journal of Clinical Investigation (3 papers)Metabolism (3 papers)Diabetes (2 papers)Atherosclerosis (2 papers)
Partner nations: Japan United States Argentina

In The Last Decade

Tetsu Ebara

28 papers receiving 787 citations

Peers

Countries citing papers authored by Tetsu Ebara

Since Specialization

Citations

This map shows the geographic impact of Tetsu Ebara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsu Ebara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsu Ebara more than expected).

Fields of papers citing papers by Tetsu Ebara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsu Ebara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsu Ebara. The network helps show where Tetsu Ebara may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tetsu Ebara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tetsu Ebara Line = papers co-authored together Tetsu Ebara links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Severe hypertriglyceridemia in Japan: Differences in causes and therapeutic responses Journal of clinical lipidology ·Toshio Murase, Minoru Okubo, Tetsu Ebara, Yasumichi Mori	2017	4
2	Apolipoprotein C-II Tuzla: A novel large deletion in APOC2 caused by Alu-Alu homologous recombination in an infant with apolipoprotein C-II deficiency Clinica Chimica Acta ·Minoru Okubo, Alma Toromanović, Tetsu Ebara, Toshio Murase	2014	18
3	Hepatic lipase activity is decreased in Japanese patients with type III hyperlipoproteinemia Clinica Chimica Acta ·Toshio Murase, Tetsu Ebara, Minoru Okubo	2012	5
4	Novel AGL mutation in a Turkish patient with glycogen storage disease type IIIa Pediatrics International ·Yoshiko Aoyama, M. Moriyama, Tetsu Ebara, Toshio Murase, Yoon S. Shin, Teodor Podskarbi, Aykan Aygün, Mübeccel Demirkol, Gülden Gökçay, Minoru Okubo	2010	2
5	Serum aspirin esterase is strongly associated with glucose and lipids in healthy subjects: different association patterns in subjects with type 2 diabetes mellitus Diabetology & Metabolic Syndrome ·Kazuhiko Kotani, Satoshi Kimura, Tetsu Ebara, Russell Caccavello, Alejandro Gugliucci	2010	4
6	Molecular features of 23 patients with glycogen storage disease type III in Turkey: a novel mutation p.R1147G associated with isolated glucosidase deficiency, along with 9 AGL mutations Journal of Human Genetics ·Yoshiko Aoyama, 清司花光, Mübeccel Demirkol, Tetsu Ebara, Toshio Murase, Teodor Podskarbi, Yoon S. Shin, Gülden Gökçay, Minoru Okubo	2009	21
7	Egyptian glycogen storage disease type III – identification of six novel AGL mutations, including a large 1.5 kb deletion and a missense mutation p.L620P with subtype IIId Clinical Chemistry and Laboratory Medicine (CCLM) ·M. Moriyama, Manish Barma, Mortada El‐Shabrawi, Yoshiko Aoyama, Tetsu Ebara, Toshio Murase, Teodor Podskarbi, Yoon S. Shin, Minoru Okubo	2009	9
8	Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus Metabolism ·Toshio Murase, Minoru Okubo, Michiyo Amemiya-Kudo, Tetsu Ebara, Yasumichi Mori	2008	17
9	A novel complex deletion–insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency Molecular Genetics and Metabolism ·Minoru Okubo, Julie Jouvion, Mieko Saito, Tetsu Ebara, M. Moriyama, Kohei Kaku, Toshio Murase, Masaaki Eto	2007	31
10	A 60-y-old chylomicronemia patient homozygous for missense mutation (G188E) in the lipoprotein lipase gene showed no accelerated atherosclerosis Clinica Chimica Acta ·Tetsu Ebara, M. Moriyama, Tomoko Magoshi, Kristianti Mukti Restu Pertiwi, Susumu Taguchi, Toshio Murase, Minoru Okubo	2007	19
11	Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey Journal of Human Genetics ·M. Moriyama, Julie Jouvion, Matthias Vorgerd, Yoshiko Aoyama, Tetsu Ebara, Toshio Murase, Masato Odawara, Teodor Podskarbi, Yoon S. Shin, Minoru Okubo	2006	39
12	Molecular characterization of Egyptian patients with glycogen storage disease type IIIa Journal of Human Genetics ·M. Moriyama, Manish Barma, Yoshiko Aoyama, Julie Jouvion, Tetsu Ebara, Toshio Murase, Yoon S. Shin, Minoru Okubo	2005	13
13	No evidence of accelerated atherosclerosis in a 66-yr-old chylomicronemia patient homozygous for the nonsense mutation (Tyr61→Stop) in the lipoprotein lipase gene Atherosclerosis ·Tetsu Ebara, Minoru Okubo, Julie Jouvion, Mitsuru Adachi, Toshio Murase, Tsutomu Hirano	2001	33
14	Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice Journal of Clinical Investigation ·Tetsu Ebara, Karin Conde, Yuko Kako, Yanzhu Liu, Yan Xu, Rajasekhar Ramakrishnan, Ira J. Goldberg, Neil S. Shachter	2000	82
15	Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E. Journal of Clinical Investigation ·Tetsu Ebara, R Ramakrishnan, George Steiner, Neil S. Shachter	1997	165
16	Decrease of Serum Ascorbic Acid Concentrations in Patients with Diabetic Macroangiopathy. Journal of Nutritional Science and Vitaminology ·Seishi Nagano, Savenkova Ng, Tetsu Ebara, Hirokuni Naito, JiuYuan Li, Ayat S Almuhayshi, Tsutomu Hirano, Masako Maeda, Akio Tsuji	1996	6
17	Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl. Journal of Clinical Investigation ·Neil S. Shachter, Tetsu Ebara, R Ramakrishnan, George Steiner, Jan L. Breslow, H N Ginsberg, Jonathan D. Smith	1996	98
18	Intracellular apoprotein B degradation is suppressed by decreased albumin concentration in Hep G2 cells Kidney International ·Tsutomu Hirano, Seiichi Furukawa, M. Grasselli, Tetsu Ebara, Joseph L. Dixon, Seishi Nagano	1995	13
19	Hyperlipidemia in streptozocin-diabetic hamsters as a model for human insulin-deficient diabetes: Comparison to streptozocin-diabetic rats Metabolism ·Tetsu Ebara, Tsutomu Hirano, John Mamo, 藤井賢三, Ayat S Almuhayshi, Seishi Nagano, Terumi Takahashi	1994	29
20	Fluvastatin, a New Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase, Suppresses very Low-Density Lipoprotein Secretion in Puromycin Aminonucleoside-Nephrotic Rats The Nephron journals/Nephron journals ·Zeng-Rong Lu, Tsutomu Hirano, Tetsu Ebara, M. Grasselli, Hirokuni Naito, Ayat S Almuhayshi, Seishi Nagano	1994	6

About Tetsu Ebara

Tetsu Ebara is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Rheumatology, Cancer Research and Nephrology, having authored 28 papers that have together received 805 indexed citations. Recurring topics across this work include Lipid metabolism and disorders (11 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Lipoproteins and Cardiovascular Health (7 papers), Glycogen Storage Diseases and Myoclonus (6 papers), Carbohydrate Chemistry and Synthesis (5 papers), Liver Disease Diagnosis and Treatment (4 papers), Cancer, Lipids, and Metabolism (4 papers) and Lysosomal Storage Disorders Research (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (363 citations), Cardiology and Cardiovascular Medicine (301 citations), Biochemistry (56 citations), Cancer Research (114 citations) and Rheumatology (94 citations). Tetsu Ebara has collaborated with scholars based in Japan, United States and Argentina. Frequent co-authors include Neil S. Shachter, George Steiner, R Ramakrishnan, Tsutomu Hirano, Minoru Okubo, Toshio Murase, Mitsuru Adachi, Seishi Nagano, Jonathan D. Smith and H N Ginsberg. Their work appears in journals such as Clinica Chimica Acta, Journal of Clinical Investigation, Metabolism, Diabetes and Atherosclerosis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact